Evaluation of Hypoxia in Primary Melanoma

NCT06831071 · clinicaltrials.gov ↗

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Pimonidazole

Sponsor

Yana Najjar

Collaborators

[object Object]